|Articles|April 13, 2003
ICL effective treatment for moderate, high hyperopia
San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul Dougherty, MD, who spoke Saturday at the American Society of Cataract and Refractive Surgery annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
2
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
3
AAVantgarde Bio closes $141 million Series B financing round
4














































.png)


